Perioperative morbidity: Lessons from recent clinical trials

Current Opinion in Critical Care

Volumn 18, Issue 4, 2012, Pages 358-365

  Thiele, Robert H ^a   Huffmyer, Julie L ^b   Raphael, Jacob ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

fluid management; goal directed therapy; perioperative infection; transfusion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE KIDNEY FAILURE; ANESTHESIA; ANESTHESIST; BACTERIUM CONTAMINATION; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; COLLOID; CRITICALLY ILL PATIENT; CRYSTALLOID; FLUID RESUSCITATION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; HEMOSTASIS; HUMAN; INTENSIVE CARE UNIT; OPERATING ROOM; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; REVIEW; RISK REDUCTION; SURGICAL INFECTION;

ACUTE KIDNEY INJURY; ANESTHESIA; BLOOD GLUCOSE; BLOOD TRANSFUSION; CLINICAL TRIALS AS TOPIC; COLLOIDS; EVIDENCE-BASED MEDICINE; HEMOSTASIS; HUMANS; INTRAOPERATIVE COMPLICATIONS; ISOTONIC SOLUTIONS; PATIENT CARE PLANNING; PERIOPERATIVE CARE; STROKE VOLUME;

EID: 84863831619     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283552af9     Document Type: Review

References (47)

1. Larson MD. History of anesthetic practice. In: Miller RD, Eriksson LI, Fleisher LA, et al., editors. Millers anesthesia, 7th edn. Vol. 1. Philadelphia: Churchill Livingstone; 2009. pp. 3-41.
2. Kohn LT, Corrigan JM. Creating safety systems in healthcare organizations. In: Kohn LT, Corrigan JM, editors. To err is human: building a safer health system. Washington, DC: National Academies Press; 2000. p. 164.
3. Vote D, Huston J. Six sigma approach to improve surgical site infections: a key variable. Am J Infect Control 2005; 33:e167-e168.
4. Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 2011; 112:1392-1402.
5. Gurgel ST, do Nascimento P Jr. Maintaining tissue perfusion in high-risk surgical patients: a systematic review of randomized clinical trials. Anesth Analg 2011; 112:1384-1391.
6. Ghosh S, Arthur B, Klein AA. NICE guidance on CardioQ(TM) oesophageal Doppler monitoring. Anaesthesia 2011; 66:1081-1083.
7. Cannesson M, Le Manach Y, Hofer CK, et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a gray zone approach. Anesthesiology 2011; 115:231-241.
8. Maguire S, Rinehart J, Vakharia S, et al. Technical communication: respiratory variation in pulse pressure and plethysmographic waveforms: intraoperative applicability in a North American academic center. Anesth Analg 2011; 112:94-96.
9. Broch O, Bein B, Gruenewald M, et al. Accuracy of the pleth variability index to predict fluid responsiveness depends on the perfusion index. Acta Anaesthesiol Scand 2011; 55:686-693.
10. Muller L, Toumi M, Bousquet PJ, et al. An increase in aortic blood flow after an infusion of 100 ml colloid over 1 min can predict fluid responsiveness: the mini-fluid challenge study. Anesthesiology 2011; 115:541-547.
11. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371:1839-1847.
12. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2009; 120: e169-e276.
13. Ellenberger C, Tait G, Beattie W S. Chronic beta blockade is associated with a better outcome after elective noncardiac surgery than acute beta blockade: a single-center propensity-matched cohort study. Anesthesiology 2011; 114: 817-823.
14. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 2012; 114:159-169.
15. Hartog CS, Bauer M, Reinhart K. The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg 2011; 112:156-164.
16. Bayer O, Reinhart K, Sakr Y, et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med 2011; 39:1335-1342.
17. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011; 112:635-645.
18. Mohnle P, Snyder-Ramos SA, Miao Y, et al. Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients. Intensive Care Med 2011; 37:97-109.
19. Parsons EC, Hough CL, Seymour CW, et al. Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shock. Crit Care 2011; 15:R221.
20. Glance LG, Dick AW, Mukamel DB, et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114:283-292.
21. Spahn DR, Shander A, Hofmann A, et al. More on transfusion and adverse outcome: its time to change. Anesthesiology 2011; 114:234-236.
22. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417.
23. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304:1559-1567.
24. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365:2453-2462.
25. Dadure C, Sauter M, Bringuier S, et al. Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: a randomized double-blind study. Anesthesiology 2011; 114:856-861.
26. Goobie SM, Meier PM, Pereira LM, et al. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 2011; 114:862-871.
27. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367.
28. Van den BergheG, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461.
29. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139.
30. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
31. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007; 146:233-243.
32. Bhamidipati CM, LaPar DJ, Stukenborg GJ, et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2011; 141:543-551.
33. Alaei F, Davari PN, Alaei M, et al. Postoperative outcome for hyperglycemic pediatric cardiac surgery patients. Pediatr Cardiol 2012; 33:21-26.
34. Moga MA, Manlhiot C, Marwali EM, et al. Hyperglycemia after pediatric cardiac surgery: impact of age and residual lesions. Crit Care Med 2011; 39:266-272.
35. Lou S, Ding F, Long C, et al. Effects of peri-operative glucose levels on adverse outcomes in infants receiving open-heart surgery for congenital heart disease with cardiopulmonary bypass. Perfusion 2011; 26:133-139.
36. Tolpin DA, Collard CD, Lee VV, et al. Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2012; 143:682-688; e681.
37. Karkouti K, Wijeysundera DN, Yau TM, et al. Influence of erythrocyte transfusion on the risk of acute kidney injury after cardiac surgery differs in anemic and nonanemic patients. Anesthesiology 2011; 115:523-530.
38. Grams ME, Estrella MM, Coresh J, et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6:966-973.
39. Wheeler AP, Bernard GR, Thompson BT, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006; 354:2213-2224.
40. Karvellas CJ, Farhat MR, Sajjad I, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011; 15:R72.
41. Loftus RW, Muffly MK, Brown JR, et al. Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission. Anesth Analg 2011; 112:98-105.
42. Koff MD, Corwin HL, Beach ML, et al. Reduction in ventilator associated pneumonia in a mixed intensive care unit after initiation of a novel hand hygiene program. J Crit Care 2011; 26:489-495.
43. Krediet AC, Kalkman CJ, Bonten MJ, et al. Hand-hygiene practices in the operating theatre: an observational study. Br J Anaesth 2011; 107:553-558.
44. Le Manach Y, Ibanez Esteves C, Bertrand M, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology 2011; 114:98-104.
45. Mekontso Dessap A, Ouanes I, Rana N, et al. Effects of discontinuing or continuing ongoing statin therapy in severe sepsis and septic shock: a retrospective cohort study. Crit Care 2011; 15:R171.
46. Kruger PS, Harward ML, Jones MA, et al. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial. Am J Respir Crit Care Med 2011; 183:774-781.
47. Prowle JR, Calzavacca P, Licari E, et al. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology (Carlton) 2011; 17:215-224.